Studies had also reported the role of FXR in lung cancer; for instance, FXR is highly expressed in NSCLC cells where the knockdown of FXR inhibits cell proliferation in vitro and reduced tumour growth in vivo. Here, NR1H4 is linked to lung carcinoma.